TiumBio Co., Ltd. (KOSDAQ: A321550)
Health Care · Biotechnology · KR
₩4,150.00
-14.96% today · -15.0% 1Y
TiumBio Co., Ltd. (KOSDAQ: A321550) operates in the Biotechnology industry within the Health Care sector. The company is valued at $89.95M.
Over the last twelve months the share price has lost 15.0%, trading between 3.42K and 13.70K.
Tweenvest scores TiumBio Co., Ltd. across four factors: quality 34/100, value 81/100. Its strongest factor is value.
A321550 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $89.95M
- Revenue (TTM)
- $8.63M
- P/E
- —
- EPS
- -536.69
- Dividend yield
- —
- Beta (5Y)
- -0.47
- 52-week high
- ₩13,700.00
- 52-week low
- ₩3,415.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.04M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.75 | -0.02% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $441.55 | -0.16% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €898.00 | +2.14% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $157.87 | -0.60% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.